Ad Blocker Detected
Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.
Venkys (India) is setting up a new project for the manufacture of veterinary medical products in the animal health product segment. For this purpose, the company has acquired land with a size of 15030 m² at MIDC, village: Kesurdi, valley: Khandala, district: Satara, Maharashtra.
Construction will begin in December 2021 and the project is expected to be completed by March 2022 and commercial production to begin by June 2022.
This project is used to produce veterinary medicinal powder (600 tons / year) and liquid veterinary medicinal products (300 kiloliters per year) in order to meet the growing demand from the poultry industry.
The total cost of the project is estimated at Rs. 30 crore financed from internal provisions.
The proposed facility will be the company’s second facility to meet the latest FDA regulations and is expected to meet export needs as well. The company already has a plant in Pune (Maharashtra) with a capacity of 600 tons / year and this capacity is used at 70-80%.
Powered by Capital Market – Live News
(This story was not edited by Business Standard staff and is automatically generated from a syndicated feed.)
Dear Reader,
Business Standard has always endeavored to provide updated information and commentary on developments that are of interest to you and have far-reaching political and economic implications for the country and the world. Your encouragement and constant feedback to improve our offering has only strengthened our determination and commitment to these ideals. Even in these troubled times resulting from Covid-19, we continue to strive to keep you updated with credible news, authoritative views, and concise comments on current affairs.
However, we have a request.
In the fight against the economic effects of the pandemic, we need your support even more so that we can continue to offer you high-quality content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscriptions to our online content can only help us achieve our goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism to which we are dedicated.
Support quality journalism and Subscribe to Business Standard.
Digital editor
